Similar articles for PMID: 21603965

Year	Number of Results
2004	1
2005	1
2007	3
2008	9
2009	13
2010	9
2011	16
2012	23
2013	9
2014	8
2015	10
2016	9
2017	10
2018	6
2019	1
2020	3
2021	3
2022	2
2023	3
2024	0

1

Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy.

Fraum TJ, Kreisl TN, Sul J, Fine HA, Iwamoto FM. Fraum TJ, et al. J Neurooncol. 2011 Nov;105(2):281-9. doi: 10.1007/s11060-011-0579-4. Epub 2011 Apr 27. J Neurooncol. 2011. PMID: 21603965 Free PMC article.

2

Antiangiogenic therapy for high-grade glioma.

Khasraw M, Ameratunga MS, Grant R, Wheeler H, Pavlakis N. Khasraw M, et al. Cochrane Database Syst Rev. 2014 Sep 22;(9):CD008218. doi: 10.1002/14651858.CD008218.pub3. Cochrane Database Syst Rev. 2014. PMID: 25242542 Updated. Review.

3

Ischemic stroke and intracranial hemorrhage in patients with recurrent glioblastoma multiforme, treated with bevacizumab.

Auer TA, Renovanz M, Marini F, Brockmann MA, Tanyildizi Y. Auer TA, et al. J Neurooncol. 2017 Jul;133(3):571-579. doi: 10.1007/s11060-017-2467-z. Epub 2017 May 29. J Neurooncol. 2017. PMID: 28555422

4

Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival.

Narayana A, Kelly P, Golfinos J, Parker E, Johnson G, Knopp E, Zagzag D, Fischer I, Raza S, Medabalmi P, Eagan P, Gruber ML. Narayana A, et al. J Neurosurg. 2009 Jan;110(1):173-80. doi: 10.3171/2008.4.17492. J Neurosurg. 2009. PMID: 18834263

5

Phase II study of single-agent bevacizumab in Japanese patients with recurrent malignant glioma.

Nagane M, Nishikawa R, Narita Y, Kobayashi H, Takano S, Shinoura N, Aoki T, Sugiyama K, Kuratsu J, Muragaki Y, Sawamura Y, Matsutani M. Nagane M, et al. Jpn J Clin Oncol. 2012 Oct;42(10):887-95. doi: 10.1093/jjco/hys121. Epub 2012 Jul 27. Jpn J Clin Oncol. 2012. PMID: 22844129 Free PMC article. Clinical Trial.

6

Patterns of progression in malignant glioma following anti-VEGF therapy: perceptions and evidence.

Wick W, Wick A, Weiler M, Weller M. Wick W, et al. Curr Neurol Neurosci Rep. 2011 Jun;11(3):305-12. doi: 10.1007/s11910-011-0184-0. Curr Neurol Neurosci Rep. 2011. PMID: 21279815 Free article. Review.

7

Bevacizumab salvage therapy following progression in high-grade glioma patients treated with VEGF receptor tyrosine kinase inhibitors.

Scott BJ, Quant EC, McNamara MB, Ryg PA, Batchelor TT, Wen PY. Scott BJ, et al. Neuro Oncol. 2010 Jun;12(6):603-7. doi: 10.1093/neuonc/nop073. Epub 2010 Feb 14. Neuro Oncol. 2010. PMID: 20156808 Free PMC article. Clinical Trial.

8

Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience.

Khasraw M, Holodny A, Goldlust SA, DeAngelis LM. Khasraw M, et al. Ann Oncol. 2012 Feb;23(2):458-63. doi: 10.1093/annonc/mdr148. Epub 2011 May 4. Ann Oncol. 2012. PMID: 21543627 Free article.

9

Antiangiogenic therapy in malignant glioma: promise and challenge.

Sathornsumetee S, Rich JN. Sathornsumetee S, et al. Curr Pharm Des. 2007;13(35):3545-58. doi: 10.2174/138161207782794130. Curr Pharm Des. 2007. PMID: 18220791 Review.

10

Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients.

Reardon DA, Herndon JE 2nd, Peters K, Desjardins A, Coan A, Lou E, Sumrall A, Turner S, Sathornsumetee S, Rich JN, Boulton S, Lipp ES, Friedman HS, Vredenburgh JJ. Reardon DA, et al. J Neurooncol. 2012 Mar;107(1):213-21. doi: 10.1007/s11060-011-0740-0. Epub 2011 Oct 14. J Neurooncol. 2012. PMID: 21997879 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year